Chronic Lymphocytic Leukemia

B-cell chronic lymphocytic leukemia (CLL) is considered a single disease with extremely variable course, and survival rates ranging from months to decades. It is clear that clinical heterogeneity reflects biologic diversity with at least two major subtypes in terms of cellular proliferation, clinica...

Descripción completa

Guardado en:
Detalles Bibliográficos
Formato: Online
Lenguaje:inglés
Publicado: IntechOpen 2021
Materias:
Acceso en línea:ONIX_20210420_9789533078816_904
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1869518084772986880
collection Directory of Open Access Books
description B-cell chronic lymphocytic leukemia (CLL) is considered a single disease with extremely variable course, and survival rates ranging from months to decades. It is clear that clinical heterogeneity reflects biologic diversity with at least two major subtypes in terms of cellular proliferation, clinical aggressiveness and prognosis. As CLL progresses, abnormal hematopoiesis results in pancitopenia and decreased immunoglobulin production, followed by nonspecific symptoms such as fatigue or malaise. A cure is usually not possible, and delayed treatment (until symptoms develop) is aimed at lengthening life and decreasing symptoms. Researchers are playing a lead role in investigating CLL's cause and the role of genetics in the pathogenesis of this disorder. Research programs are dedicated towards understanding the basic mechanisms underlying CLL with the hope of improving treatment options.
format Online
id doab-20.500.12854ir-65547
institution Directory of Open Access Books
language eng
publishDate 2021
publishDateRange 2021
publishDateSort 2021
publisher IntechOpen
publisherStr IntechOpen
record_format ojs
spelling doab-20.500.12854ir-655472024-03-31T22:43:59Z Chronic Lymphocytic Leukemia Oppezzo, Pablo Musculoskeletal medicine thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJD Cardiovascular medicine B-cell chronic lymphocytic leukemia (CLL) is considered a single disease with extremely variable course, and survival rates ranging from months to decades. It is clear that clinical heterogeneity reflects biologic diversity with at least two major subtypes in terms of cellular proliferation, clinical aggressiveness and prognosis. As CLL progresses, abnormal hematopoiesis results in pancitopenia and decreased immunoglobulin production, followed by nonspecific symptoms such as fatigue or malaise. A cure is usually not possible, and delayed treatment (until symptoms develop) is aimed at lengthening life and decreasing symptoms. Researchers are playing a lead role in investigating CLL's cause and the role of genetics in the pathogenesis of this disorder. Research programs are dedicated towards understanding the basic mechanisms underlying CLL with the hope of improving treatment options. 2021-04-20T15:20:00Z 2021-04-20T15:20:00Z 2012 book ONIX_20210420_9789533078816_904 9789533078816 9789535167464 https://directory.doabooks.org/handle/20.500.12854/65547 eng image/jpeg n/a https://www.intechopen.com/books https://mts.intechopen.com/storage/books/647/authors_book/authors_book.pdf IntechOpen IntechOpen 10.5772/1156 10.5772/1156 78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6 9789533078816 9789535167464 IntechOpen 464 open access
spellingShingle Musculoskeletal medicine
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJD Cardiovascular medicine
Chronic Lymphocytic Leukemia
title Chronic Lymphocytic Leukemia
title_full Chronic Lymphocytic Leukemia
title_fullStr Chronic Lymphocytic Leukemia
title_full_unstemmed Chronic Lymphocytic Leukemia
title_short Chronic Lymphocytic Leukemia
title_sort chronic lymphocytic leukemia
topic Musculoskeletal medicine
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJD Cardiovascular medicine
topic_facet Musculoskeletal medicine
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJD Cardiovascular medicine
url ONIX_20210420_9789533078816_904